Literature DB >> 16079138

SRC regulates constitutive internalization and rapid resensitization of a cholecystokinin 2 receptor splice variant.

Celia Chao1, Kirk L Ives, Elizabeth Goluszko, Andrey A Kolokoltsov, Robert A Davey, Courtney M Townsend, Mark R Hellmich.   

Abstract

The third intracellular loop domain of G protein-coupled receptors regulates their desensitization, internalization, and resensitization. Colorectal and pancreatic cancers, but not the nonmalignant tissue, express a splice variant of the cholecystokinin 2 receptor (CCK2R) called CCK(2i4sv)R that, because of intron 4 retention, contains an additional 69 amino acids within its third intracellular loop domain. This structural alteration is associated with agonist-independent activation of Src kinase (Olszewska-Pazdrak, B., Townsend, C. M., Jr., and Hellmich, M. R. (2004) J. Biol. Chem. 279, 40400-40404). The purpose of the study was to determine the roles of intron 4 retention and Src kinase on CCK(2i4sv)R desensitization, internalization, and resensitization. Gastrin1-17 (G17) binds to both CCK2R and CCK(2i4sv)R and induces intracellular Ca2+ ([Ca2+]i) increases. Agonist-induced increases in [Ca2+]i were used to assess receptor activity. Src kinase activity was inhibited by transducing cells with a retrovirus containing a dominant-negative mutant Src (A430V). The subcellular location of enhanced green fluorescent protein-tagged receptors was monitored using laser scanning confocal microscopy. Both receptor variants desensitized at the same rate; however, CCK(2i4sv)R resensitized five times faster than CCK2R. Without agonist, 80% of CCK(2i4sv)R is located in an intracellular compartment. In contrast, 80% of CCK2R was located on the plasma membrane. Treatment with inverse agonist (YM022) or expression of dominant-negative Src blocked the constitutive internalization of CCK(2i4sv)R, resulting in its accumulation on the plasma membrane. Expression of dominant-negative Src slowed the rate of CCK(2i4sv)R resensitization. Inhibition of Src did not affect G17-induced internalization of either receptor variant. Constitutive internalization of CCK(2i4sv)R increases its rate of resensitization by creating an intracellular pool of receptors that can rapidly recycle back to the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16079138     DOI: 10.1074/jbc.M506337200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Role of AMP-18 in oral mucositis.

Authors:  Peili Chen; Mark Lingen; Stephen T Sonis; Margaret M Walsh-Reitz; F Gary Toback
Journal:  Oral Oncol       Date:  2011-07-06       Impact factor: 5.337

Review 2.  Function of alternative splicing.

Authors:  Olga Kelemen; Paolo Convertini; Zhaiyi Zhang; Yuan Wen; Manli Shen; Marina Falaleeva; Stefan Stamm
Journal:  Gene       Date:  2012-08-15       Impact factor: 3.688

3.  Somatic mutations in CCK2R alter receptor activity that promote oncogenic phenotypes.

Authors:  Melinda D Willard; Mary E Lajiness; Isabella H Wulur; Bo Feng; Michelle L Swearingen; Mark T Uhlik; Kenneth W Kinzler; Victor E Velculescu; Tobias Sjöblom; Sanford D Markowitz; Steven M Powell; Bert Vogelstein; Thomas D Barber
Journal:  Mol Cancer Res       Date:  2012-04-19       Impact factor: 5.852

4.  G-protein coupled receptor resensitization-appreciating the balancing act of receptor function.

Authors:  Maradumane L Mohan; Neelakantan T Vasudevan; Manveen K Gupta; Elizabeth E Martelli; S V Naga Prasad
Journal:  Curr Mol Pharmacol       Date:  2012-05-30       Impact factor: 3.339

5.  Inhibition of non-receptor tyrosine kinase Src induces phosphoserine 256-independent aquaporin-2 membrane accumulation.

Authors:  Pui W Cheung; Abby Terlouw; Sam Antoon Janssen; Dennis Brown; Richard Bouley
Journal:  J Physiol       Date:  2018-12-21       Impact factor: 5.182

6.  CCK2 receptor expression transforms non-tumorigenic human NCM356 colonic epithelial cells into tumor forming cells.

Authors:  Celia Chao; Xueliang Han; Kirk Ives; Jeseong Park; Andrey A Kolokoltsov; Robert A Davey; Mary P Moyer; Mark R Hellmich
Journal:  Int J Cancer       Date:  2010-02-15       Impact factor: 7.396

7.  CCK(2) receptor splice variant with intron 4 retention in human gastrointestinal and lung tumours.

Authors:  Meike Körner; Beatrice Waser; Jean Claude Reubi; Laurence J Miller
Journal:  J Cell Mol Med       Date:  2009-07-20       Impact factor: 5.310

8.  Computational analysis of splicing errors and mutations in human transcripts.

Authors:  Yerbol Z Kurmangaliyev; Mikhail S Gelfand
Journal:  BMC Genomics       Date:  2008-01-14       Impact factor: 3.969

9.  Src promotes delta opioid receptor (DOR) desensitization by interfering with receptor recycling.

Authors:  Elodie Archer-Lahlou; Nicolas Audet; Mohammad Gholi Amraei; Karine Huard; Mélanie Paquin-Gobeil; Graciela Pineyro
Journal:  J Cell Mol Med       Date:  2008-03-19       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.